Details

Published: 28 May 2019

From May 22 to 25, 2019, Medsintez took part in the VIII (XXVI) National Congress of Endocrinologists "Personified Medicine and Practical Health Care".

Read more ...

Details

Published: 29 April 2019

From April 16 to 19, Urals Healthcare 2019, the specialized International Exhibition and Forum, was held at the Yekaterinburg Expo Centre, where a stand of Medsintez was presented too. The forum exhibition of medical equipment, tools, supplies, pharmaceuticals as well as medical and spa services was held for the first time ever.

Read more ...

Details

Published: 10 January 2019

On December 21, 2018, Epidemiology And Treatment Of Allergic Diseases, a scientific and practical conference of the Sverdlovsk region's allergologists and immunologists, was held, where Triazavirin, the domestic antiviral drug, was recommended as a treatment for viral infections that exacerbate bronchial asthma.

Read more ...

Details

Published: 18 December 2018

Today, the company has a developed technology for obtaining the RosinsulinAspart and RosinsulinGlargin substances as well as their dosage forms.

Read more ...

Details

Published: 22 November 2018

On November 15, 2018, within the framework of a regular meeting of the Sverdlovsk Association of Endocrinologists, the results of clinical trials of Rosinsulin M Mix 30/70, 2-phase genetically engineered human insulin, were presented in Rymar Oksana's report “Basic clinical and laboratory parameters in patients with type 2 diabetes mellitus amid the therapy of combined domestic insulins and metformins in the real-world clinical practice."

Read more ...